Biogen Inc (BIIB)

Days of sales outstanding (DSO)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Receivables turnover		6.89	5.91	5.97	7.09	7.03
DSO	days	52.99	61.75	61.17	51.50	51.96

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 6.89
= 52.99

Based on the provided data, Biogen Inc's Days Sales Outstanding (DSO) has shown a fluctuating trend over the past five years. As of December 31, 2020, the DSO was 51.96 days, which decreased slightly to 51.50 days by December 31, 2021. However, there was a notable increase in DSO to 61.17 days by December 31, 2022, and this trend continued with a further increase to 61.75 days by December 31, 2023.

The DSO then decreased to 52.99 days by December 31, 2024, which is closer to the levels seen in 2020 and 2021. Overall, the DSO metric provides insights into how long it takes Biogen to collect payments from its sales, with lower numbers indicating quicker collections and better liquidity management. The recent variations in DSO may suggest changes in the company's credit policies, customer payment behavior, or efficiency in managing accounts receivable. Further analysis and comparison with industry benchmarks would be valuable to assess Biogen's performance in managing its receivables effectively.